Kolon TissueGene, Inc. is a biotechnology company based in Rockville, MD, specializing in the development of innovative cell and gene therapies. With a strong focus on research and development, the company aims to revolutionize the treatment of various diseases and conditions through its cutting-edge technology, TG-C.
Driven by a dedicated management team and supported by a distinguished board of directors and advisory boards, Kolon TissueGene is committed to advancing its product pipeline, which includes applications in clinical trials. As a leader in the field, the company actively seeks partnerships and alliances to further enhance its impact on the healthcare industry.
Generated from the website